Skip to content
Governance Register

← US public companies

Codiak Biosciences, Inc.

SEC CIK 1659352 · CDAK · last insider filing 2023-03-30

Directors (from insider filings)

NameCapacity as filedFilings
Williams Douglas E Director · See Remarks filed 2020 - 2023
Cooney Charles L Director filed 2020 - 2023
Melas Kyriazi Theo Director filed 2020 - 2023
Gillis Steven Director filed 2020 - 2023
Bernstein Karen Director filed 2020 - 2023
Haddock Jason Director filed 2020 - 2023
Pandite Arundathy N. Director filed 2021 - 2022
Eggimann Anne-Virginie Director filed 2021 - 2022
Morrison Briggs Director filed 2020 - 2021
Lander Eric S Director filed 2020 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Bain Linda Chief Financial Officer filed 2020 - 2023
Konstantinov Konstantin See Remarks filed 2020 - 2023
Barna Nicole See Remarks filed 2020 - 2023
Howze Yalonda See Remarks filed 2020 - 2023
Sathyanarayanan Sriram Chief Scientific Officer filed 2021 - 2023
Mauro David J Chief Medical Officer filed 2022 - 2023
Brudnick Richard See Remarks filed 2020 - 2022
Sorensen Benny See Remarks filed 2020 - 2021
Wheler Jennifer J. Chief Medical Officer filed 2021 - 2021
Verma Ajay See Remarks filed 2020 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.